Twin Tree Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-17,800
Closed -$2.38M 1674
2025
Q3
$2.38M Buy
+17,800
New +$2.16M 0.01% 997
2024
Q4
Sell
-27,200
Closed -$4.05M 1867
2024
Q3
$4.05M Hold
27,200
0.01% 964
2024
Q2
$3.43M Sell
27,200
-33,100
-55% -$5.19M 0.01% 851
2024
Q1
$11.1M Sell
60,300
-97,500
-62% -$18.6M 0.02% 607
2023
Q4
$28.4M Buy
157,800
+117,200
+289% +$18.2M 0.05% 355
2023
Q3
$6.46M Buy
40,600
+38,400
+1,745% +$6.28M 0.01% 623
2023
Q2
$311K Sell
2,200
-2,000
-48% -$321K ﹤0.01% 1091
2023
Q1
$707K Sell
4,200
-11,400
-73% -$2.03M ﹤0.01% 1048
2022
Q4
$2.64M Buy
+15,600
New +$2.83M 0.01% 881
2022
Q3
Sell
-10,500
Closed -$1.71M 1637
2022
Q2
$1.71M Sell
10,500
-12,300
-54% -$1.95M ﹤0.01% 1110
2022
Q1
$4.29M Buy
22,800
+13,500
+145% +$2.56M 0.01% 972
2021
Q4
$2.46M Buy
+9,300
New +$2.51M 0.01% 1051

Other funds holding RGEN

Twin Tree Management's RGEN Position: Q2 2025 in Review

Twin Tree Management sold out of Repligen (RGEN) in Q2 2025, closing a stake of 226 shares — an estimated $28.8K sold.

Twin Tree Management first reported a position in RGEN in Q1 2019 and held it in 12 quarters. The position peaked at $12.4M in Q4 2022. 443 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

  • Twin Tree Management reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
  • Twin Tree Management sold 226 Repligen shares in Q2 2025, an estimated $28.8K.
  • Twin Tree Management first reported a position in Repligen in Q1 2019 and held it in 12 quarters.
  • Twin Tree Management's Repligen position peaked at $12.4M in Q4 2022.
  • 443 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on Twin Tree Management's 13F filing for Q2 2025, filed 28 Jul 2025.